← FDA Drug Approvals (Drugs@FDA)
PREGABALIN
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ZYDUS PHARMS · Approved 2022-12-09
Drug application
- FDA Application #
ANDA206752- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- PREGABALIN
- Generic name
- Pregabalin
- Active ingredients
- PREGABALIN
- Dosage form
- CAPSULE
- Route
- ORAL
- Marketing status
- Discontinued
- Sponsor
- ZYDUS PHARMS
- First approval
- 2022-12-09
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown